coronavirus vaccine

Novavax’s Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

A Centers for Disease Control and Prevention advisory committee on Saturday endorsed Pfizer-BioNTech and Moderna’s Covid-19 vaccines for young children, the last step before Director Dr. Rochelle Walensky can issue her final signoff.

U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.

White House officials say orders have been coming in for COVID-19 vaccine doses for small children. Federal authorization of shots for U.S. kids under 5 is possible next week. The government last week began allowing pharmacies and states to place orders, with 5 million doses initially available. So far, about 1.45 million of the 2.5 million available doses of Pfizer...

The 18 million kids under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.

The center’s director, Dr. Rochelle Walensky, adopted a panel’s recommendation Thursday.

Kids ages 5 to 11 should get a booster dose of Pfizer’s COVID-19 vaccine, advisers to the U.S. government said Thursday.

The FDA announced Tuesday that it has expanded eligibility for the Pfizer booster shot to include children ages 5 to 11.

Boosters could become available as early as Friday if approved by the CDC, which could come Thursday.

President Joe Biden has appealed to world leaders for a renewed international commitment to attacking COVID-19 as he leads the U.S. in marking the “tragic milestone” of 1 million deaths in America

Don’t want to carry about your physical vaccine card? Here’s how to add it to your iPhone.

Secretary of State Antony Blinken has tested positive for COVID-19 and is experiencing mild symptoms, his spokesperson confirmed Wednesday.

A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.

The FDA’s top vaccine regulator, Dr. Peter Marks, said shortly after the decision that another round of boosters will likely be needed in the fall.

The FDA’s committee of vaccine experts will meet Wednesday to discuss how the U.S. should go about changing the current ones if needed.

The FDA and CDC announced Tuesday that both agencies had expanded eligibility for a second booster shot of the Pfizer or Moderna coronavirus vaccines for all adults over the age of 50.

Drugmaker Moderna has asked the Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults

Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over.

Pfizer and its partner BioNTech asked U.S. regulators to authorize an additional booster dose of their COVID-19 vaccine for seniors